Evidence map›Paper›PMID 35186325›Full record

ArticleVirus evolution2021

Genomic analysis of human noroviruses using combined Illumina-Nanopore data.

Annika Flint, Spencer Reaume, Jennifer Harlow, Emily Hoover, Kelly Weedmark, Neda Nasheri

Open access · goldAbstract read
In one paragraph

Article in Virus evolution, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. [Development of a Reverse Transcription Loop-Mediated Isothermal Amplification Assay for the Detection of Genogroup Ⅱ Norovirus].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Annika FlintGenomics Laboratory, Bureau of Microbial Hazards, Health Canada, Ottawa, ON, Canada.
Spencer ReaumeNational Food Virology Reference Centre, Bureau of Microbial Hazards, Health Canada, Ottawa, ON, Canada.
Jennifer HarlowNational Food Virology Reference Centre, Bureau of Microbial Hazards, Health Canada, Ottawa, ON, Canada.
Emily HooverGenomics Laboratory, Bureau of Microbial Hazards, Health Canada, Ottawa, ON, Canada.
Kelly WeedmarkGenomics Laboratory, Bureau of Microbial Hazards, Health Canada, Ottawa, ON, Canada.
Neda NasheriNational Food Virology Reference Centre, Bureau of Microbial Hazards, Health Canada, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0003-0736-0423
Health Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole-genome sequence analysis of noroviruses is routinely performed by employing a metagenomic approach. While this methodology has several advantages, such as allowing for the examination of co-infection, it has some limitations, such as the requirement of high viral load to achieve full-length or near full-length genomic sequences. In this study, we used a pre-amplification step to obtain full-length genomic amplicons from 39 Canadian GII isolates, followed by deep sequencing on Illumina and Oxford Nanopore platforms. This approach significantly reduced the required viral titre to obtain full-genome coverage. Herein, we compared the coverage and sequences obtained by both platforms and provided an in-depth genomic analysis of the obtained sequences, including the presence of single-nucleotide variants and recombination events.

Indexed as

full-length ampliconsIllumina MiSeqnorovirusOxford Nanoporerecombinationsingle-nucleotide variation

Identifiers

PMID35186325
PMCPMC8570145
OpenAlexW3199048638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.